Immunic
IMUX
24 hedge funds and large institutions have $17.6M invested in Immunic in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 25 closing their positions.
1,581% more call options, than puts
Call options by funds: $4.62M | Put options by funds: $275K
1,415% more capital invested
Capital invested by funds: $1.16M → $17.6M (+$16.5M)
1.5% more ownership
Funds ownership: 0.03% → 1.54% (+1.5%)
44% less funds holding
Funds holding: 43 → 24 (-19)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
76% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$18M |
| 2 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$920K |
| 3 |
Millennium Management
New York
|
+$392K |
| 4 |
Renaissance Technologies
New York
|
+$176K |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$423K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$107K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$80K |
| 4 |
State Street
Boston,
Massachusetts
|
-$77K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$69K |
IMUX Hedge Fund Activity: Q2 2019 in Review
24 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2019, worth a combined $17.6M — up 1,415% from $1.16M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of IMUX and 6 opened new positions — a net loss of 19 holders — while 9 trimmed existing stakes and 5 added.
The largest buyer was Omega Fund Management, opening a new position worth an estimated $18M. The largest seller was BlackRock, cutting an estimated $423K.
- 24 institutional investors held Immunic (IMUX) as of Q2 2019, down from 43 in Q1 2019.
- Funds reported $17.6M of Immunic stock for Q2 2019, up 1,415% quarter-over-quarter.
- 6 funds opened new Immunic positions in Q2 2019 and 25 closed out, a net change of -19 holders.
- The largest Immunic buyer in Q2 2019 was Omega Fund Management, an estimated $18M added.
- The largest Immunic seller in Q2 2019 was BlackRock, an estimated $423K sold.
Based on aggregated 13F filings for Q2 2019.